RGS4 is a negative regulator of insulin release from pancreatic beta-cells in vitro and in vivo.
Therapeutic strategies that augment insulin release from pancreatic beta-cells are considered beneficial in the treatment of type 2 diabetes. We previously demonstrated that activation of beta-cell M(3) muscarinic receptors (M3Rs) greatly promotes glucose-stimulated insulin secretion (GSIS), suggesting that strategies aimed at enhancing signaling through beta-cell M3Rs may become therapeutically useful. M3R activation leads to the stimulation of G proteins of the G(q) family, which are under the inhibitory control of proteins known as regulators of G protein signaling (RGS proteins). At present, it remains unknown whether RGS proteins play a role in regulating insulin release. To address this issue, we initially demonstrated that MIN6 insulinoma cells express functional M3Rs and that RGS4 was by far the most abundant RGS protein expressed by these cells. Strikingly, siRNA-mediated knockdown of RGS4 expression in MIN6 cells greatly enhanced M3R-mediated augmentation of GSIS and calcium release. We obtained similar findings using pancreatic islets prepared from RGS4-deficient mice. Interestingly, RGS4 deficiency had little effect on insulin release caused by activation of other beta-cell GPCRs. Finally, treatment of mutant mice selectively lacking RGS4 in pancreatic beta-cells with a muscarinic agonist (bethanechol) led to significantly increased plasma insulin and reduced blood glucose levels, as compared to control littermates. Studies with beta-cell-specific M3R knockout mice showed that these responses were mediated by beta-cell M3Rs. These findings indicate that RGS4 is a potent negative regulator of M3R function in pancreatic beta-cells, suggesting that RGS4 may represent a potential target to promote insulin release for therapeutic purposes.
Ruiz de Azua
Inigo
I
Molecular Signaling Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
Scarselli
Marco
M
Rosemond
Erica
E
Gautam
Dinesh
D
Jou
William
W
Gavrilova
Oksana
O
Ebert
Philip J
PJ
Levitt
Pat
P
Wess
Jürgen
J
D000704:Analysis of Variance; D000818:Animals; D018723:Bethanechol; D001786:Blood Glucose / Q000378:metabolism; D015153:Blotting, Western; D019556:COS Cells; D002118:Calcium / Q000378:metabolism; D045744:Cell Line, Tumor; D002522:Chlorocebus aethiops; D018274:Electroporation; D047468:Immunoprecipitation; D007328:Insulin / Q000378:metabolism*; D000078790:Insulin Secretion; D050417:Insulin-Secreting Cells / Q000378:metabolism*; D051379:Mice; D020710:RGS Proteins / Q000378:metabolism*; D043587:Receptor, Muscarinic M3 / Q000378:metabolism*; D020133:Reverse Transcriptase Polymerase Chain Reaction
D001786:Blood Glucose; D007328:Insulin; D020710:RGS Proteins; D043587:Receptor, Muscarinic M3; D018723:Bethanechol; C098799:RGS4 protein; D002118:Calcium
Crit Rev Neurobiol. 1996;10(1):69-99
8853955
Neuroscience. 2006 Nov 3;142(4):1163-81
16989953
Biol Psychiatry. 2006 Sep 15;60(6):534-7
16860780
J Clin Invest. 2007 Dec;117(12):4034-43
17992256
Biochemistry. 2009 Mar 17;48(10):2282-9
19182865
Nat Neurosci. 2006 Jun;9(6):832-42
16699510
Nature. 2003 Mar 13;422(6928):173-6
12629551
Cell Signal. 2006 May;18(5):579-91
16226429
Diabetes. 2004 Jul;53(7):1714-20
15220195
Pharmacol Rev. 2002 Sep;54(3):527-59
12223533
Nat Rev Mol Cell Biol. 2002 Sep;3(9):639-50
12209124
J Biol Chem. 1999 Feb 5;274(6):3549-56
9920901
Neuroscience. 2006 Nov 3;142(4):1145-61
16996696
Trends Pharmacol Sci. 2008 Aug;29(8):413-20
18606460
J Biol Chem. 1999 Jan 1;274(1):305-15
9867845
Nature. 2001 Dec 13;414(6865):821-7
11742415
Endocrinology. 2008 Nov;149(11):5706-12
18635652
Biochem Pharmacol. 2008 Jan 1;75(1):76-84
17880927
Pharmacol Ther. 2007 Dec;116(3):473-95
18006065
Cancer Res. 2009 Jul 15;69(14):5743-51
19549919
Cell Metab. 2006 Jun;3(6):449-61
16753580
Methods Enzymol. 2004;389:3-15
15313556
Mol Syst Biol. 2009;5:291
19638972
Biochem Biophys Res Commun. 2004 Mar 19;315(4):872-6
14985093
Eur J Neurosci. 2004 Jun;19(11):3125-8
15182322
Nat Rev Drug Discov. 2002 Mar;1(3):187-97
12120503
Semin Cell Dev Biol. 2006 Jun;17(3):383-9
16647283
Diabetes. 1989 Nov;38(11):1433-8
2576006
Nat Rev Drug Discov. 2009 May;8(5):369-85
19365392
J Biol Chem. 2007 Mar 9;282(10):7385-96
17213190
Diabetologia. 1993 Nov;36(11):1139-45
8270128
Circ Res. 2008 Aug 29;103(5):527-35
18658048
Endocr Rev. 2001 Oct;22(5):565-604
11588141
Diabetologia. 2003 Jan;46(1):3-19
12637977
Annu Rev Biochem. 2000;69:795-827
10966476
Mol Pharmacol. 2008 Aug;74(2):338-47
18388243
J Biol Chem. 2004 Jan 23;279(4):2593-9
14604980
Am J Transplant. 2010 Feb;10(2):231-41
19958325